PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Coeptis Therapeutics Holdings, Inc.
Filed: November 7, 2023
Period of Report: November 7, 2023
Accession Number: 0001683168-23-007679

View Document ↗ View on SEC.gov ↗